FI894072L - Polypeptider anvaendbara som vaccin. - Google Patents

Polypeptider anvaendbara som vaccin. Download PDF

Info

Publication number
FI894072L
FI894072L FI894072A FI894072A FI894072L FI 894072 L FI894072 L FI 894072L FI 894072 A FI894072 A FI 894072A FI 894072 A FI894072 A FI 894072A FI 894072 L FI894072 L FI 894072L
Authority
FI
Finland
Prior art keywords
polypeptider
vaccin
anvaendbara som
anvaendbara
som
Prior art date
Application number
FI894072A
Other languages
English (en)
Finnish (fi)
Other versions
FI894072A7 (fi
FI894072A0 (fi
Inventor
James Francis Young
Christopher S Jones
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of FI894072A0 publication Critical patent/FI894072A0/fi
Publication of FI894072A7 publication Critical patent/FI894072A7/fi
Publication of FI894072L publication Critical patent/FI894072L/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/145—Amines having sulfur, e.g. thiurams (>N—C(S)—S—C(S)—N< and >N—C(S)—S—S—C(S)—N<), Sulfinylamines (—N=SO), Sulfonylamines (—N=SO2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/10—Cellular immunotherapy characterised by the cell type used
    • A61K40/11—T-cells, e.g. tumour infiltrating lymphocytes [TIL] or regulatory T [Treg] cells; Lymphokine-activated killer [LAK] cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
    • A61K40/46—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K40/00
    • A61K2239/31—Indexing codes associated with cellular immunotherapy of group A61K40/00 characterized by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K40/00
    • A61K2239/38—Indexing codes associated with cellular immunotherapy of group A61K40/00 characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
FI894072A 1988-08-31 1989-08-30 Polypeptider anvaendbara som vaccin. FI894072L (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23880388A 1988-08-31 1988-08-31
US38755889A 1989-07-28 1989-07-28

Publications (3)

Publication Number Publication Date
FI894072A0 FI894072A0 (fi) 1989-08-30
FI894072A7 FI894072A7 (fi) 1990-03-01
FI894072L true FI894072L (fi) 1990-03-01

Family

ID=26931978

Family Applications (1)

Application Number Title Priority Date Filing Date
FI894072A FI894072L (fi) 1988-08-31 1989-08-30 Polypeptider anvaendbara som vaccin.

Country Status (9)

Country Link
EP (1) EP0366239A1 (de)
AU (1) AU640348B2 (de)
DK (1) DK428589A (de)
FI (1) FI894072L (de)
HU (1) HUT54732A (de)
IL (1) IL91456A0 (de)
NO (1) NO893472L (de)
NZ (1) NZ230459A (de)
PT (1) PT91601A (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5766601A (en) * 1990-08-08 1998-06-16 University Of Massachusetts Medical Center Cross-reactive influenza a immunization
FR2692898B1 (fr) * 1992-06-30 1995-06-02 Centre Nat Rech Scient Procédé d'obtention de protéines membranaires, et utilisation de ces protéines dans un but de diagnostic ou de vaccination.
WO1994019013A1 (en) * 1993-02-19 1994-09-01 Smithkline Beecham Corporation Influenza vaccine compositions containing 3-o-deacylated monophosphoryl lipid a
US9119810B2 (en) * 2005-11-18 2015-09-01 Rutgers, The State University Of New Jersey Compositions and vaccines against influenza A and influenza B infections
WO2012009790A1 (en) 2010-07-22 2012-01-26 Schrader John W Cross-protective pathogen protection, methods and compositions thereof
KR102905685B1 (ko) 2018-03-26 2025-12-30 베링거 인겔하임 애니멀 헬스 유에스에이 인크. 면역원성 조성물의 제조방법

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2477417A1 (fr) * 1980-03-07 1981-09-11 Pasteur Institut Nouvelles fractions douees de proprietes antigeniques isolees de virus grippal, leur procede de preparation et leur application therapeutique en tant qu'agents vaccinants
AR241713A1 (es) * 1984-08-30 1992-11-30 Smithkline Beckman Corp Molecula de dna con una secuencia de bases que codifica la proteina c13 y preparacion de vacunas contra la gripe.

Also Published As

Publication number Publication date
FI894072A7 (fi) 1990-03-01
NO893472D0 (no) 1989-08-30
NO893472L (no) 1990-03-01
NZ230459A (en) 1993-04-28
PT91601A (pt) 1990-03-30
FI894072A0 (fi) 1989-08-30
HUT54732A (en) 1991-03-28
IL91456A0 (en) 1990-04-29
EP0366239A1 (de) 1990-05-02
DK428589D0 (da) 1989-08-30
DK428589A (da) 1990-03-01
AU640348B2 (en) 1993-08-26
AU4022589A (en) 1990-03-08

Similar Documents

Publication Publication Date Title
FI893334A0 (fi) Trycksensitiva bindemedel som innehaoller en alkoxifunktionell kiselfoerening.
FI896138A0 (fi) Polyolpolyestrar som fuktighetsbarriaer foer livsmedel.
FI921279A0 (fi) Amino-b-lyasenzyminhibitorer som deodoranter.
FI895792A0 (fi) Bild-display-anordning som anvaender alternering i svepriktning.
FI881570L (fi) Differentialutgaongens koppling som enpolig.
FI900763A0 (fi) Tris-hydroximetyl-laegre alkanestrar som fettsurrogat.
FI881910L (fi) Underlag i synnerhet foer personer som saknar roerelsefoermaoga.
FI894600L (fi) Ny sammansaettning som innehaoller isocyanat-reaktiva vaete innehaollande foereningar.
FI892214L (fi) Kopparlegering foer anvaendning som motstaondssvetselektrod.
FI895483L (fi) Som slaglod anvaendbara kopparblandningar.
FI890033A7 (fi) Bildskaermanordning som innehaoller en vaogformsgenerator.
FI894072A0 (fi) Polypeptider anvaendbara som vaccin.
FI890147A7 (fi) Aemnen som motverkar rytmstoerningar.
FI893863L (fi) Foerfarande foer neutralisering av svavelsyra som innehaoller zinkjoner.
FI890798L (fi) Foerfarande foer diacylering av foereningar som innehaoller tvao aromatiska kaernor.
FI900940A0 (fi) Tryckt kretsskiva som foerhindrar elektromagnetisk interferens.
FI905238A0 (fi) Foerbraenningsmotor foer fartyg som transporterar foerbraenningsgas.
FI894475L (fi) Anvaendning av sampolymerisat innehaollande aminogrupper i vattenbaserade kompositioner som grundfaerg.
FI893162L (fi) Som 19-hydroxylasinhibitorer anvaendbara 19-fluor- eller cyano-21-hydroxiprogesteronderivat.
FI905274A0 (fi) Katod som frigoer vaete.
FI881817A0 (fi) Maskinhelhet som hopsaetts av luftkonditionerings-,luftrenings-,vaermeutjaemnings-och dammsugningsmoduler.
FI910281A0 (fi) Kopplingsarrangemang som bildar triangelpuls.
FI881591A0 (fi) Vaermeradiator som lagrar vaermeenergi.
FI880902A0 (fi) Landsvaegskonstruktion som minskar spaorbildning.
FI894664L (fi) Inpassningskil foer vaeggelement som skall sammanfogas.

Legal Events

Date Code Title Description
FD Application lapsed
MM Patent lapsed

Owner name: SMITHKLINE BEECHAM CORPORATION